Dr. Lamba’s News Stories

These are links to recent news stories featuring Jatinder Lamba, Ph.D., and her research lab.

2015

https://ufhealth.org/news/2015/tailor-cancer-treatment-study-uses-computer-simulation-model-patient-cancer-dna

2017

http://gatorx.pharmacy.ufl.edu/files/2017/10/Gatorx2015.pdf

https://www.fredhutch.org/en/news/center-news/2017/06/mylotarg-precision-medicine.html

http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(17)30507-7/fulltext

http://www.oncotherapynetwork.com/leukemia-lymphoma/anti-leukemic-drug-gemtuzumab-ozogamicin-may-benefit-some-aml-patients

http://www.hematology.org/Thehematologist/Diffusion/7883.aspx

http://www.ascopost.com/News/57834

2019

Online Publications:

An interview and our research on pharmacogenomics in leukemia (Title: Paths to Precise Prescriptions) was highlighted in International Innovations Journal. https://cop-main.sites.medinfo.ufl.edu/files/2014/08/Paths-to-Precise-Prescriptions.pdf )

http://www.scientiapublications.com/jatinder-lamba-science-diffusion/
Title: The genetic Puzzle: why do we respond to cancer therapy?

https://www.openaccessgovernment.org/personalising-antibody-directed-therapy-acute-myeloid-leukaemia/39415/
Title: Personalising antibody directed therapy in Acute Myeloid Leukaemia (AML) (Nov.2017)

https://www.openaccessgovernment.org/acute-myeloid-leukaemia-aml-cytarabine-pharmacogenomics/42053/
Title: Acute Myeloid Leukemia and cytarabine pharmacogenomics (Feb 2, 2018)

https://www.openaccessgovernment.org/acute-myeloid-leukaemia-aml-research-and-application/44874/
Title: Acute Myeloid Leukemia (AML research and Application (April 20, 2018)

https://www.openaccessgovernment.org/cd33-directed-therapy/
Title: CD33 directed therapy: Current and future perspective in acute myeloid leukemia (AML) (Sept. 2018)